Zymeworks Return on Equity (ROE) Growth & History (ZYME)

Zymeworks's return on equity was −26.72% for fiscal 2025.

View full Zymeworks company overview

Zymeworks annual return on equity history

Zymeworks annual return on equity

Fiscal yearPeriod endedReturn on equityChange (percentage points)
20252025-12-31−26.72%+3.82 pp
20242024-12-31−30.54%−5.76 pp
20232023-12-31−24.78%−58.29 pp
20222022-12-3133.51%+97.80 pp
20212021-12-31−64.29%

Zymeworks return on equity trends

Between the periods ended 2021-12-31 and 2025-12-31, Zymeworks's return on equity increased from −64.29% to −26.72%, a change of +37.57 percentage points. The latest reported quarter, Q2 2026, shows −36.91%.

About the metric

What return on equity (ROE) means

Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.

Calculation and source

How return on equity is calculated

TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Zymeworks source filings ↗

Community posts

It’s quiet here.

No posts about ZYME yet. Start the conversation.

Write the first post